Ionic conductivity in Li2O-Al2O3-SiO2 based glasses and glass ceramics

The complex conductivity of lithium aluminosilicate based glasses and glass-ceramics (Zerodur from Schott) has been investigated in a broad range of temperatures (200 K &lt; T &lt; 700 K) and frequencies (10 mHz&lt;v&lt;2.5 THz). The data are presented in terms of the conductivity and the electrical modulus formalisms. The width of the modulus loss peak as measured for the ceramic sample is broader than that determined for its precursor glass. This result is shown to be associated with the considerably smaller dc conductivity of this material.</jats:p

Tensile Creep and Creep-Recovery Behavior of a SiC-Fiber Si 3 N 4 -Matrix Composite

Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/65802/1/j.1151-2916.1993.tb03753.x.pd

Single particle jumps and correlated ionic motions in glass-ceramics

Using impedance spectroscopy, the ion transport in poorly Li-conducting aluminosilicate glass ceramics and their precursor glasses has been measured for temperatures 50 K < T < 550 K and covering a frequency range of more than 14 decades from 10 mHz up to 3 THz. In addition to the familiar cooperative ionic motion dominating at high temperatures, for the first time dielectric relaxation due to elementary hopping processes is observed well below room temperature

BoHV-1-Vectored BVDV-2 Subunit Vaccine Induces BVDV Cross-Reactive Cellular Immune Responses and Protects against BVDV-2 Challenge

The bovine respiratory disease complex (BRDC) remains a major problem for both beef and dairy cattle industries worldwide. BRDC frequently involves an initial viral respiratory infection resulting in immunosuppression, which creates a favorable condition for fatal secondary bacterial infection. Current polyvalent modified live vaccines against bovine herpesvirus type 1(BoHV-1) and bovine viral diarrhea virus (BVDV) have limitations concerning their safety and efficacy. To address these shortcomings and safety issues, we have constructed a quadruple gene mutated BoHV-1 vaccine vector (BoHV-1 QMV), which expresses BVDV type 2, chimeric E2 and Flag-tagged Erns-fused with bovine granulocyte monocyte colony-stimulating factor (GM-CSF) designated here as QMV-BVD2*. Here we compared the safety, immunogenicity, and protective efficacy of QMV-BVD2* vaccination in calves against BVDV-2 with Zoetis Bovi-shield Gold 3 trivalent (BoHV-1, BVDV types 1 and 2) vaccine. The QMV-BVD2* prototype subunit vaccine induced the BoHV-1 and BVDV-2 neutralizing antibody responses along with BVDV-1 and -2 cross-reactive cellular immune responses. Moreover, after a virulent BVDV-2 challenge, the QMV-BVD2* prototype subunit vaccine conferred a more rapid recall BVDV-2-specific neutralizing antibody response and considerably better recall BVDV types 1 and 2-cross protective cellular immune responses than that of the Zoetis Bovi-shield Gold 3